CFGI Sentiment Reports · 15 quarters on record since 5 Jan 2023 · updated daily, as of 8 Sep 2026
Vertex Pharmaceuticals Quarterly Sentiment Reports
Every quarter of Vertex Pharmaceuticals (VRTX) sentiment since 5 Jan 2023, newest first. Each quarter lists its price performance, high, low and average, its sentiment high, low and average, its most volatile day for each, the chart of the whole quarter, the 10 sub-algorithm averages and a short summary. Q3 2026 is the running quarter: an average of 57 (Neutral).
Vertex Pharmaceuticals sentiment at a glance
- Quarters on record
- 15, since 5 Jan 2023
- Average sentiment, all closed quarters
- 52 of 100 (Neutral)
- Greediest quarter
- Q2 2023, average 59 (Neutral)
- Most fearful quarter
- Q2 2025, average 44 (Neutral)
- Best quarter for the VRTX price
- Q1 2025, +19.5%
- Worst quarter for the VRTX price
- Q4 2024, -14.3%
- Running quarter
- Q3 2026, average 57 (Neutral), VRTX price +5.9%
Updated daily; last reading . Every number is computed from CFGI's stored daily readings.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2026 | -1.2%47 | +11.1%48 | +5.9%57 | - |
| 2025 | +19.5%57 | -8.2%44 | -13.4%45 | +12.2%56 |
| 2024 | +1.7%55 | +11.5%56 | -1.3%52 | -14.3%45 |
| 2023 | +9.4%56 | +11.2%59 | 0.0%51 | +17.0%56 |
Vertex Pharmaceuticals Q3 2026 Sentiment Report
to In progress, updates daily| Performance | +5.9% | 1 Jul 2026 to 8 Sep 2026 |
|---|---|---|
| Price high | $557.96 | 3 Sep 2026 |
| Price low | $470.72 | 3 Aug 2026 |
| Average price | $510.20 | |
| Sentiment high | 87Extreme Greed | 7 Jul 2026 |
| Sentiment low | 29Fear | 14 Jul 2026 |
| Average sentiment | 57Neutral | |
| Most volatile day (price) | +6.0% | 2 Jul 2026 |
| Most volatile day (sentiment) | -52 points (87 to 35) | 9 Jul 2026 |
47 scored trading days of 50. Price is the VRTX price; performance is the first to the last scored day.
Q3 2026 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2026, in its own band colour.
- Price60
- Volatility56
- Volume55
- Momentum56
- Technical62
- Social49
- Dominance61
- Trends34
- Whales49
- Orders50
Q3 2026 in brief
Vertex Pharmaceuticals is averaging 57 of 100 (Neutral) across 47 scored trading days in Q3 2026, opening at 72 on 1 Jul 2026 and reading 34 on 8 Sep 2026. Sentiment ran from 29 (Fear) on 14 Jul 2026 to 87 (Extreme Greed) on 7 Jul 2026. The VRTX price moved +5.9% from $498.01 to $527.51, with its biggest single-day move of +6.0% on 2 Jul 2026. The quarter is still open and updates daily.
Vertex Pharmaceuticals Q2 2026 Sentiment Report
to| Performance | +11.1% | 1 Apr 2026 to 30 Jun 2026 |
|---|---|---|
| Price high | $499.65 | 29 Jun 2026 |
| Price low | $423.24 | 29 Apr 2026 |
| Average price | $443.19 | |
| Sentiment high | 80Extreme Greed | 29 Jun 2026 |
| Sentiment low | 28Fear | 3 Jun 2026 |
| Average sentiment | 48Neutral | |
| Most volatile day (price) | +3.4% | 22 Jun 2026 |
| Most volatile day (sentiment) | -24 points (67 to 43) | 15 May 2026 |
62 scored trading days of 65. Price is the VRTX price; performance is the first to the last scored day.
Q2 2026 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2026, in its own band colour.
- Price50
- Volatility50
- Volume52
- Momentum55
- Technical48
- Socialn/a
- Dominance18
- Trendsn/a
- Whales39
- Orders59
Q2 2026 in brief
Vertex Pharmaceuticals averaged 48 of 100 (Neutral) across 62 scored trading days in Q2 2026, opening at 48 on 1 Apr 2026 and closing at 77 on 30 Jun 2026. Sentiment ran from 28 (Fear) on 3 Jun 2026 to 80 (Extreme Greed) on 29 Jun 2026. The VRTX price moved +11.1% from $447.26 to $496.73, with its biggest single-day move of +3.4% on 22 Jun 2026.
Vertex Pharmaceuticals Q1 2026 Sentiment Report
to| Performance | -1.2% | 2 Jan 2026 to 31 Mar 2026 |
|---|---|---|
| Price high | $499.17 | 10 Mar 2026 |
| Price low | $433.07 | 27 Mar 2026 |
| Average price | $466.29 | |
| Sentiment high | 76Greed | 7 Jan 2026 |
| Sentiment low | 26Fear | 15 Jan 2026 |
| Average sentiment | 47Neutral | |
| Most volatile day (price) | +8.3% | 10 Mar 2026 |
| Most volatile day (sentiment) | +41 points (29 to 70) | 10 Mar 2026 |
61 scored trading days of 64. Price is the VRTX price; performance is the first to the last scored day.
Q1 2026 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2026, in its own band colour.
- Price52
- Volatility47
- Volume48
- Momentum47
- Technical57
- Socialn/a
- Dominance25
- Trendsn/a
- Whales38
- Orders34
Q1 2026 in brief
Vertex Pharmaceuticals averaged 47 of 100 (Neutral) across 61 scored trading days in Q1 2026, opening at 46 on 2 Jan 2026 and closing at 34 on 31 Mar 2026. Sentiment ran from 26 (Fear) on 15 Jan 2026 to 76 (Greed) on 7 Jan 2026. The VRTX price moved -1.2% from $452.13 to $446.54, with its biggest single-day move of +8.3% on 10 Mar 2026.
Vertex Pharmaceuticals Q4 2025 Sentiment Report
to| Performance | +12.2% | 1 Oct 2025 to 31 Dec 2025 |
|---|---|---|
| Price high | $463.13 | 3 Dec 2025 |
| Price low | $402.90 | 6 Oct 2025 |
| Average price | $431.03 | |
| Sentiment high | 75Greed | 4 Dec 2025 |
| Sentiment low | 32Fear | 7 Nov 2025 |
| Average sentiment | 56Neutral | |
| Most volatile day (price) | +6.9% | 3 Dec 2025 |
| Most volatile day (sentiment) | -30 points (74 to 44) | 8 Dec 2025 |
64 scored trading days of 66. Price is the VRTX price; performance is the first to the last scored day.
Q4 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q4 2025, in its own band colour.
- Price59
- Volatility56
- Volume57
- Momentum57
- Technical59
- Socialn/a
- Dominance14
- Trendsn/a
- Whales62
- Orders52
Q4 2025 in brief
Vertex Pharmaceuticals averaged 56 of 100 (Neutral) across 64 scored trading days in Q4 2025, opening at 65 on 1 Oct 2025 and closing at 48 on 31 Dec 2025. Sentiment ran from 32 (Fear) on 7 Nov 2025 to 75 (Greed) on 4 Dec 2025. The VRTX price moved +12.2% from $404.21 to $453.36, with its biggest single-day move of +6.9% on 3 Dec 2025.
Vertex Pharmaceuticals Q3 2025 Sentiment Report
to| Performance | -13.4% | 1 Jul 2025 to 30 Sep 2025 |
|---|---|---|
| Price high | $479.53 | 10 Jul 2025 |
| Price low | $366.54 | 8 Aug 2025 |
| Average price | $417.92 | |
| Sentiment high | 72Greed | 10 Jul 2025 |
| Sentiment low | 13Extreme Fear | 5 Aug 2025 |
| Average sentiment | 45Neutral | |
| Most volatile day (price) | -20.6% | 5 Aug 2025 |
| Most volatile day (sentiment) | -40 points (53 to 13) | 5 Aug 2025 |
64 scored trading days of 66. Price is the VRTX price; performance is the first to the last scored day.
Q3 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2025, in its own band colour.
- Price46
- Volatility46
- Volume47
- Momentum50
- Technical46
- Socialn/a
- Dominance10
- Trendsn/a
- Whales80
- Orders28
Q3 2025 in brief
Vertex Pharmaceuticals averaged 45 of 100 (Neutral) across 64 scored trading days in Q3 2025, opening at 51 on 1 Jul 2025 and closing at 57 on 30 Sep 2025. Sentiment ran from 13 (Extreme Fear) on 5 Aug 2025 to 72 (Greed) on 10 Jul 2025. The VRTX price moved -13.4% from $452.16 to $391.64, with its biggest single-day move of -20.6% on 5 Aug 2025.
Vertex Pharmaceuticals Q2 2025 Sentiment Report
to| Performance | -8.2% | 1 Apr 2025 to 30 Jun 2025 |
|---|---|---|
| Price high | $509.50 | 30 Apr 2025 |
| Price low | $421.16 | 14 May 2025 |
| Average price | $460.83 | |
| Sentiment high | 74Greed | 15 Apr 2025 |
| Sentiment low | 13Extreme Fear | 9 May 2025 |
| Average sentiment | 44Neutral | |
| Most volatile day (price) | -10.0% | 6 May 2025 |
| Most volatile day (sentiment) | -32 points (50 to 18) | 6 May 2025 |
62 scored trading days of 65. Price is the VRTX price; performance is the first to the last scored day.
Q2 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2025, in its own band colour.
- Price45
- Volatility51
- Volume53
- Momentum49
- Technical45
- Socialn/a
- Dominance42
- Trendsn/a
- Whalesn/a
- Orders25
Q2 2025 in brief
Vertex Pharmaceuticals averaged 44 of 100 (Neutral) across 62 scored trading days in Q2 2025, opening at 31 on 1 Apr 2025 and closing at 37 on 30 Jun 2025. Sentiment ran from 13 (Extreme Fear) on 9 May 2025 to 74 (Greed) on 15 Apr 2025. The VRTX price moved -8.2% from $484.74 to $445.20, with its biggest single-day move of -10.0% on 6 May 2025.
Vertex Pharmaceuticals Q1 2025 Sentiment Report
to| Performance | +19.5% | 2 Jan 2025 to 31 Mar 2025 |
|---|---|---|
| Price high | $513.76 | 17 Mar 2025 |
| Price low | $402.49 | 6 Jan 2025 |
| Average price | $466.00 | |
| Sentiment high | 84Extreme Greed | 5 Feb 2025 |
| Sentiment low | 29Fear | 2 Jan 2025 |
| Average sentiment | 57Neutral | |
| Most volatile day (price) | +5.3% | 31 Jan 2025 |
| Most volatile day (sentiment) | -26 points (78 to 52) | 7 Feb 2025 |
60 scored trading days of 64. Price is the VRTX price; performance is the first to the last scored day.
Q1 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2025, in its own band colour.
- Price58
- Volatility60
- Volume62
- Momentum61
- Technical59
- Socialn/a
- Dominance36
- Trendsn/a
- Whalesn/a
- Orders65
Q1 2025 in brief
Vertex Pharmaceuticals averaged 57 of 100 (Neutral) across 60 scored trading days in Q1 2025, opening at 29 on 2 Jan 2025 and closing at 34 on 31 Mar 2025. Sentiment ran from 29 (Fear) on 2 Jan 2025 to 84 (Extreme Greed) on 5 Feb 2025. The VRTX price moved +19.5% from $405.76 to $484.82, with its biggest single-day move of +5.3% on 31 Jan 2025.
Vertex Pharmaceuticals Q4 2024 Sentiment Report
to| Performance | -14.3% | 1 Oct 2024 to 31 Dec 2024 |
|---|---|---|
| Price high | $516.74 | 8 Nov 2024 |
| Price low | $396.64 | 19 Dec 2024 |
| Average price | $463.53 | |
| Sentiment high | 80Extreme Greed | 8 Nov 2024 |
| Sentiment low | 12Extreme Fear | 19 Dec 2024 |
| Average sentiment | 45Neutral | |
| Most volatile day (price) | -11.4% | 19 Dec 2024 |
| Most volatile day (sentiment) | +30 points (44 to 74) | 5 Nov 2024 |
64 scored trading days of 66. Price is the VRTX price; performance is the first to the last scored day.
Q4 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q4 2024, in its own band colour.
- Price47
- Volatility47
- Volume47
- Momentum48
- Technical50
- Socialn/a
- Dominance30
- Trendsn/a
- Whalesn/a
- Orders42
Q4 2024 in brief
Vertex Pharmaceuticals averaged 45 of 100 (Neutral) across 64 scored trading days in Q4 2024, opening at 53 on 1 Oct 2024 and closing at 26 on 31 Dec 2024. Sentiment ran from 12 (Extreme Fear) on 19 Dec 2024 to 80 (Extreme Greed) on 8 Nov 2024. The VRTX price moved -14.3% from $469.76 to $402.70, with its biggest single-day move of -11.4% on 19 Dec 2024.
Vertex Pharmaceuticals Q3 2024 Sentiment Report
to| Performance | -1.3% | 1 Jul 2024 to 30 Sep 2024 |
|---|---|---|
| Price high | $505.78 | 1 Aug 2024 |
| Price low | $460.00 | 23 Sep 2024 |
| Average price | $480.37 | |
| Sentiment high | 76Greed | 10 Jul 2024 |
| Sentiment low | 23Fear | 7 Aug 2024 |
| Average sentiment | 52Neutral | |
| Most volatile day (price) | -4.1% | 3 Sep 2024 |
| Most volatile day (sentiment) | -32 points (75 to 43) | 3 Sep 2024 |
64 scored trading days of 66. Price is the VRTX price; performance is the first to the last scored day.
Q3 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2024, in its own band colour.
- Price53
- Volatility49
- Volume50
- Momentum51
- Technical57
- Socialn/a
- Dominance66
- Trendsn/a
- Whalesn/a
- Orders41
Q3 2024 in brief
Vertex Pharmaceuticals averaged 52 of 100 (Neutral) across 64 scored trading days in Q3 2024, opening at 46 on 1 Jul 2024 and closing at 45 on 30 Sep 2024. Sentiment ran from 23 (Fear) on 7 Aug 2024 to 76 (Greed) on 10 Jul 2024. The VRTX price moved -1.3% from $471.25 to $465.08, with its biggest single-day move of -4.1% on 3 Sep 2024.
Vertex Pharmaceuticals Q2 2024 Sentiment Report
to| Performance | +11.5% | 1 Apr 2024 to 28 Jun 2024 |
|---|---|---|
| Price high | $485.53 | 6 Jun 2024 |
| Price low | $392.81 | 30 Apr 2024 |
| Average price | $434.05 | |
| Sentiment high | 87Extreme Greed | 5 Jun 2024 |
| Sentiment low | 27Fear | 4 Apr 2024 |
| Average sentiment | 56Neutral | |
| Most volatile day (price) | +3.3% | 3 Jun 2024 |
| Most volatile day (sentiment) | +25 points (44 to 69) | 31 May 2024 |
63 scored trading days of 65. Price is the VRTX price; performance is the first to the last scored day.
Q2 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2024, in its own band colour.
- Price57
- Volatility55
- Volume54
- Momentum56
- Technical58
- Socialn/a
- Dominance51
- Trendsn/a
- Whalesn/a
- Orders49
Q2 2024 in brief
Vertex Pharmaceuticals averaged 56 of 100 (Neutral) across 63 scored trading days in Q2 2024, opening at 55 on 1 Apr 2024 and closing at 46 on 28 Jun 2024. Sentiment ran from 27 (Fear) on 4 Apr 2024 to 87 (Extreme Greed) on 5 Jun 2024. The VRTX price moved +11.5% from $420.48 to $468.72, with its biggest single-day move of +3.3% on 3 Jun 2024.
Vertex Pharmaceuticals Q1 2024 Sentiment Report
to| Performance | +1.7% | 2 Jan 2024 to 28 Mar 2024 |
|---|---|---|
| Price high | $446.08 | 30 Jan 2024 |
| Price low | $407.69 | 15 Mar 2024 |
| Average price | $422.74 | |
| Sentiment high | 84Extreme Greed | 16 Jan 2024 |
| Sentiment low | 27Fear | 6 Mar 2024 |
| Average sentiment | 55Neutral | |
| Most volatile day (price) | -3.0% | 6 Feb 2024 |
| Most volatile day (sentiment) | -31 points (64 to 33) | 2 Feb 2024 |
61 scored trading days of 65. Price is the VRTX price; performance is the first to the last scored day.
Q1 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2024, in its own band colour.
- Price57
- Volatility56
- Volume55
- Momentum52
- Technical57
- Socialn/a
- Dominance65
- Trendsn/a
- Whalesn/a
- Orders40
Q1 2024 in brief
Vertex Pharmaceuticals averaged 55 of 100 (Neutral) across 61 scored trading days in Q1 2024, opening at 72 on 2 Jan 2024 and closing at 51 on 28 Mar 2024. Sentiment ran from 27 (Fear) on 6 Mar 2024 to 84 (Extreme Greed) on 16 Jan 2024. The VRTX price moved +1.7% from $410.91 to $418.01, with its biggest single-day move of -3.0% on 6 Feb 2024.
Vertex Pharmaceuticals Q4 2023 Sentiment Report
to| Performance | +17.0% | 2 Oct 2023 to 29 Dec 2023 |
|---|---|---|
| Price high | $410.68 | 15 Dec 2023 |
| Price low | $343.00 | 16 Nov 2023 |
| Average price | $369.42 | |
| Sentiment high | 88Extreme Greed | 15 Dec 2023 |
| Sentiment low | 19Extreme Fear | 16 Nov 2023 |
| Average sentiment | 56Neutral | |
| Most volatile day (price) | +13.2% | 13 Dec 2023 |
| Most volatile day (sentiment) | -33 points (68 to 35) | 9 Nov 2023 |
63 scored trading days of 65. Price is the VRTX price; performance is the first to the last scored day.
Q4 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q4 2023, in its own band colour.
- Price56
- Volatility57
- Volume54
- Momentum56
- Technical58
- Socialn/a
- Dominance65
- Trendsn/a
- Whalesn/a
- Orders47
Q4 2023 in brief
Vertex Pharmaceuticals averaged 56 of 100 (Neutral) across 63 scored trading days in Q4 2023, opening at 45 on 2 Oct 2023 and closing at 71 on 29 Dec 2023. Sentiment ran from 19 (Extreme Fear) on 16 Nov 2023 to 88 (Extreme Greed) on 15 Dec 2023. The VRTX price moved +17.0% from $347.83 to $406.89, with its biggest single-day move of +13.2% on 13 Dec 2023.
Vertex Pharmaceuticals Q3 2023 Sentiment Report
to| Performance | 0.0% | 3 Jul 2023 to 29 Sep 2023 |
|---|---|---|
| Price high | $362.46 | 21 Jul 2023 |
| Price low | $338.18 | 7 Jul 2023 |
| Average price | $349.73 | |
| Sentiment high | 73Greed | 18 Jul 2023 |
| Sentiment low | 31Fear | 7 Aug 2023 |
| Average sentiment | 51Neutral | |
| Most volatile day (price) | +3.1% | 2 Aug 2023 |
| Most volatile day (sentiment) | -19 points (62 to 43) | 22 Sep 2023 |
63 scored trading days of 65. Price is the VRTX price; performance is the first to the last scored day.
Q3 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2023, in its own band colour.
- Price52
- Volatility51
- Volume48
- Momentum50
- Technical55
- Socialn/a
- Dominance47
- Trendsn/a
- Whalesn/a
- Orders53
Q3 2023 in brief
Vertex Pharmaceuticals averaged 51 of 100 (Neutral) across 63 scored trading days in Q3 2023, opening at 55 on 3 Jul 2023 and closing at 45 on 29 Sep 2023. Sentiment ran from 31 (Fear) on 7 Aug 2023 to 73 (Greed) on 18 Jul 2023. The VRTX price moved 0.0% from $347.57 to $347.74, with its biggest single-day move of +3.1% on 2 Aug 2023.
Vertex Pharmaceuticals Q2 2023 Sentiment Report
to| Performance | +11.2% | 3 Apr 2023 to 30 Jun 2023 |
|---|---|---|
| Price high | $351.91 | 30 Jun 2023 |
| Price low | $314.42 | 4 Apr 2023 |
| Average price | $336.94 | |
| Sentiment high | 81Extreme Greed | 1 May 2023 |
| Sentiment low | 26Fear | 31 May 2023 |
| Average sentiment | 59Neutral | |
| Most volatile day (price) | +5.0% | 27 Apr 2023 |
| Most volatile day (sentiment) | +27 points (26 to 53) | 2 Jun 2023 |
62 scored trading days of 65. Price is the VRTX price; performance is the first to the last scored day.
Q2 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2023, in its own band colour.
- Price60
- Volatility58
- Volume57
- Momentum56
- Technical60
- Socialn/a
- Dominance64
- Trendsn/a
- Whalesn/a
- Orders48
Q2 2023 in brief
Vertex Pharmaceuticals averaged 59 of 100 (Neutral) across 62 scored trading days in Q2 2023, opening at 64 on 3 Apr 2023 and closing at 63 on 30 Jun 2023. Sentiment ran from 26 (Fear) on 31 May 2023 to 81 (Extreme Greed) on 1 May 2023. The VRTX price moved +11.2% from $316.33 to $351.91, with its biggest single-day move of +5.0% on 27 Apr 2023.
Vertex Pharmaceuticals Q1 2023 Sentiment Report
to| Performance | +9.4% | 5 Jan 2023 to 31 Mar 2023 |
|---|---|---|
| Price high | $323.10 | 31 Jan 2023 |
| Price low | $283.23 | 9 Jan 2023 |
| Average price | $300.38 | |
| Sentiment high | 94Extreme Greed | 17 Jan 2023 |
| Sentiment low | 24Fear | 3 Feb 2023 |
| Average sentiment | 56Neutral | |
| Most volatile day (price) | -4.9% | 8 Feb 2023 |
| Most volatile day (sentiment) | -43 points (86 to 43) | 9 Jan 2023 |
60 scored trading days of 65. Price is the VRTX price; performance is the first to the last scored day.
Q1 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2023, in its own band colour.
- Price54
- Volatility61
- Volume61
- Momentum54
- Technical49
- Socialn/a
- Dominance47
- Trendsn/a
- Whalesn/a
- Orders41
Q1 2023 in brief
Vertex Pharmaceuticals averaged 56 of 100 (Neutral) across 60 scored trading days in Q1 2023, opening at 84 on 5 Jan 2023 and closing at 64 on 31 Mar 2023. Sentiment ran from 24 (Fear) on 3 Feb 2023 to 94 (Extreme Greed) on 17 Jan 2023. The VRTX price moved +9.4% from $287.89 to $315.07, with its biggest single-day move of -4.9% on 8 Feb 2023.
How these reports are built
Each quarter is computed from CFGI's stored daily readings of the Fear and Greed Index: the last 1d reading of every UTC day in the window, its 10 components and the stored daily VRTX price. Averages are over scored trading days only. A running quarter updates with every data cycle; a closed quarter is final. Cite as: CFGI, Vertex Pharmaceuticals Quarterly Sentiment Reports, cfgi.io, 8 Sep 2026, https://cfgi.io/vertex-pharmaceuticals-stock-quarterly-report/.
Frequently asked questions
Where do these Vertex Pharmaceuticals quarterly reports come from?
What is the most volatile day?
How does a quarter get a Partial record tag?
Where are the monthly reports?
CFGI is a sentiment gauge, not financial advice. It does not predict price or tell users when to trade. These reports describe what the crowd did; they are a mirror of the crowd, not a forecast.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.